Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Stomach Neoplasms × Cetuximab × Clear all

Phase

Phase 2 12 Phase 1/2 3 Phase 1 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 34 Squamous Cell Carcinoma of Head and Neck 22 Head and Neck Neoplasms 12 Colonic Neoplasms 12 Rectal Neoplasms 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Neoplasm Metastasis 5 Carcinoma, Non-Small-Cell Lung 5 Recurrence 3 Carcinoma 3 Mouth Neoplasms 2 Lung Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Carcinoma, Squamous Cell 2 Stomach Neoplasms 1 Rectal Diseases 1 Radiation Injuries 1 Precancerous Conditions 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Head Neck Cancer Squamous Cell Recurrent 1 Gastrointestinal Neoplasms 1

Interventions

Oxaliplatin 49 Capecitabine 41 Fluorouracil 30 Cisplatin 29 S 1 (combination) 21 Docetaxel 16 Paclitaxel 15 Leucovorin 14 pembrolizumab 10 apatinib 10 Irinotecan 10 XELOX 9 titanium silicide 8 Nivolumab 8 Epirubicin 8 Drug Therapy 8 Hyperthermic Intraperitoneal Chemotherapy 7 Radiotherapy 6 Neoadjuvant Therapy 6 gimeracil 5 Trastuzumab 5 Tegafur 5 Chemotherapy, Adjuvant 5 Surgical Procedures, Operative 4 Ramucirumab 4 Gastrectomy 4 zolbetuximab 3 tislelizumab 3 sintilimab 3 potassium oxonate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00678535 2014-07-21

EXPAND

Merck KGaA, Darmstadt, Germany

Phase 3 Completed

904 enrolled 12 charts

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡